Pancreatitis following administration of iodixanol in patients on hemodialysis

A pilot study

M. Kheda, L. Brenner, D. Riggans, Vamsi Kota, H. M. Szerlip

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background and objectives: We previously described the association of pancreatitis with the use of iodixanol radiocontrast in two patients on hemodialysis. This study was designed to determine whether there might be a causal link. Design: 30 consecutive hemodialysis patients without predisposition for pancreatitis who were undergoing declotting and angioplasty of their arteriovenous access were randomly assigned to either iodixanol or iohexol radiocontrast. Results: The demographics and volume of contrast used were similar between the groups. 2 of the 15 patients who received iodixanol developed elevations in serum amylase and lipase as well as signs and symptoms of pancreatitis. No patient who received iohexol developed pancreatitis. Conclusion: The use of iodixanol appears to be associated with pancreatitis in a small population of hemodialysis patients. Although the pathogenesis of iodixanol-induced pancreatitis is unclear, we speculate that it is possibly related to the hyperviscosity of this agent, which may decrease pancreatic blood flow. Larger studies are needed to verify these findings.

Original languageEnglish (US)
Pages (from-to)381-384
Number of pages4
JournalClinical Nephrology
Volume73
Issue number5
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Pancreatitis
Renal Dialysis
Iohexol
Amylases
Lipase
Angioplasty
Signs and Symptoms
iodixanol
Demography
Serum
Population

Keywords

  • Hemodialysis
  • Pancreatitis
  • Radiocontrast

ASJC Scopus subject areas

  • Nephrology

Cite this

Pancreatitis following administration of iodixanol in patients on hemodialysis : A pilot study. / Kheda, M.; Brenner, L.; Riggans, D.; Kota, Vamsi; Szerlip, H. M.

In: Clinical Nephrology, Vol. 73, No. 5, 01.01.2010, p. 381-384.

Research output: Contribution to journalArticle

Kheda, M. ; Brenner, L. ; Riggans, D. ; Kota, Vamsi ; Szerlip, H. M. / Pancreatitis following administration of iodixanol in patients on hemodialysis : A pilot study. In: Clinical Nephrology. 2010 ; Vol. 73, No. 5. pp. 381-384.
@article{8f89d72ae3554ec9887cfc646aa89867,
title = "Pancreatitis following administration of iodixanol in patients on hemodialysis: A pilot study",
abstract = "Background and objectives: We previously described the association of pancreatitis with the use of iodixanol radiocontrast in two patients on hemodialysis. This study was designed to determine whether there might be a causal link. Design: 30 consecutive hemodialysis patients without predisposition for pancreatitis who were undergoing declotting and angioplasty of their arteriovenous access were randomly assigned to either iodixanol or iohexol radiocontrast. Results: The demographics and volume of contrast used were similar between the groups. 2 of the 15 patients who received iodixanol developed elevations in serum amylase and lipase as well as signs and symptoms of pancreatitis. No patient who received iohexol developed pancreatitis. Conclusion: The use of iodixanol appears to be associated with pancreatitis in a small population of hemodialysis patients. Although the pathogenesis of iodixanol-induced pancreatitis is unclear, we speculate that it is possibly related to the hyperviscosity of this agent, which may decrease pancreatic blood flow. Larger studies are needed to verify these findings.",
keywords = "Hemodialysis, Pancreatitis, Radiocontrast",
author = "M. Kheda and L. Brenner and D. Riggans and Vamsi Kota and Szerlip, {H. M.}",
year = "2010",
month = "1",
day = "1",
doi = "10.5414/CNP73381",
language = "English (US)",
volume = "73",
pages = "381--384",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "5",

}

TY - JOUR

T1 - Pancreatitis following administration of iodixanol in patients on hemodialysis

T2 - A pilot study

AU - Kheda, M.

AU - Brenner, L.

AU - Riggans, D.

AU - Kota, Vamsi

AU - Szerlip, H. M.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Background and objectives: We previously described the association of pancreatitis with the use of iodixanol radiocontrast in two patients on hemodialysis. This study was designed to determine whether there might be a causal link. Design: 30 consecutive hemodialysis patients without predisposition for pancreatitis who were undergoing declotting and angioplasty of their arteriovenous access were randomly assigned to either iodixanol or iohexol radiocontrast. Results: The demographics and volume of contrast used were similar between the groups. 2 of the 15 patients who received iodixanol developed elevations in serum amylase and lipase as well as signs and symptoms of pancreatitis. No patient who received iohexol developed pancreatitis. Conclusion: The use of iodixanol appears to be associated with pancreatitis in a small population of hemodialysis patients. Although the pathogenesis of iodixanol-induced pancreatitis is unclear, we speculate that it is possibly related to the hyperviscosity of this agent, which may decrease pancreatic blood flow. Larger studies are needed to verify these findings.

AB - Background and objectives: We previously described the association of pancreatitis with the use of iodixanol radiocontrast in two patients on hemodialysis. This study was designed to determine whether there might be a causal link. Design: 30 consecutive hemodialysis patients without predisposition for pancreatitis who were undergoing declotting and angioplasty of their arteriovenous access were randomly assigned to either iodixanol or iohexol radiocontrast. Results: The demographics and volume of contrast used were similar between the groups. 2 of the 15 patients who received iodixanol developed elevations in serum amylase and lipase as well as signs and symptoms of pancreatitis. No patient who received iohexol developed pancreatitis. Conclusion: The use of iodixanol appears to be associated with pancreatitis in a small population of hemodialysis patients. Although the pathogenesis of iodixanol-induced pancreatitis is unclear, we speculate that it is possibly related to the hyperviscosity of this agent, which may decrease pancreatic blood flow. Larger studies are needed to verify these findings.

KW - Hemodialysis

KW - Pancreatitis

KW - Radiocontrast

UR - http://www.scopus.com/inward/record.url?scp=77951663002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951663002&partnerID=8YFLogxK

U2 - 10.5414/CNP73381

DO - 10.5414/CNP73381

M3 - Article

VL - 73

SP - 381

EP - 384

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 5

ER -